• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Janssen's Tremfya gets go-ahead from NICE in plaque psoriasis pharmafile
    May 15, 2018
    NICE, the UK’s drug watchdog for the NHS, has decided that Janssen’s Tremfya (guselkumab) should be used routinely through the health service in the treatment of plaque psoriasis, having judged it an efficient use of financial resources.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service